Faruqi & Faruqi, LLP is Investigating AmerisourceBergen Corporation on Behalf of its Shareholders
Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and the enforcement of federal antitrust laws, is investigating potential wrongdoing at AmerisourceBergen Corporation (“ABC” or the “Company”) (NYSE: ABC). The investigation focuses on whether certain officers and directors of ABC violated their fiduciary duties to the Company by failing to ensure that ABC had adequate internal controls to prevent the diversion of controlled substances to illegitimate channels.
On August 9, 2012, ABC, a prescription drug wholesaler, disclosed that it had received subpoenas from the U.S. Attorney’s Office in New Jersey and the Drug Enforcement Agency (“DEA”) involving the Company’s processes for handling controlled substances. The subpoenas are connected to a grand jury proceeding seeking documents about ABC’s program for controlling and monitoring the diversion of controlled substances into illegitimate channels. Furthermore, in June 2012, the West Virginia Attorney General filed a lawsuit against the Company alleging that ABC failed to provide effective controls and procedures to guard against the diversion of controlled substances for illegal purposes in West Virginia.
If you are a current ABC shareholder, and you would like to discuss your legal rights, contact us by calling Beth A. Keller toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com.
Please tell us about yourself by completing the form below and we will provide you with additional
information on how to join the Action.
* The submission of this form does not create an attorney-client relationship.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.